Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 15,746 shares at $8.96 ($141K) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Seasonal sale ($141k) by CHIEF EXECUTIVE OFFICER — this insider has traded TVTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.96 | 7,873 | $71K | 50.0% |
| 2 | $8.96 | 7,873 | $71K | 50.0% |
| Total | $8.96 avg | 15,746 | $141K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |